142 related articles for article (PubMed ID: 15359574)
1. Transport characteristics of fexofenadine in the Caco-2 cell model.
Petri N; Tannergren C; Rungstad D; Lennernäs H
Pharm Res; 2004 Aug; 21(8):1398-404. PubMed ID: 15359574
[TBL] [Abstract][Full Text] [Related]
2. Cellular Uptake and Transport Characteristics of FL118 Derivatives in Caco-2 Cell Monolayers.
Zhou Y; Hu W; Zhang X; Wang Y; Zhuang W; Li F; Li Q
Chem Pharm Bull (Tokyo); 2021; 69(11):1054-1060. PubMed ID: 34719586
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the intestinal absorption of morroniside from Cornus officinalis Sieb. et Zucc via a Caco-2 cell monolayer model.
Xu R; Zhu H; Hu L; Yu B; Zhan X; Yuan Y; Zhou P
PLoS One; 2020; 15(5):e0227844. PubMed ID: 32470043
[TBL] [Abstract][Full Text] [Related]
4. Chiral Discrimination of P-glycoprotein in Parturient Women: Effect of Fluoxetine on Maternal-Fetal Fexofenadine Pharmacokinetics.
Pinto L; Moreira FL; Nardotto GHB; Cavalli RC; Moisés ECD; Duarte G; Lanchote VL
Pharm Res; 2020 Jun; 37(7):131. PubMed ID: 32557079
[TBL] [Abstract][Full Text] [Related]
5. The Effects of Jabara Juice on the Intestinal Permeation of Fexofenadine.
Han H; Akiyoshi T; Morita T; Tsuchitani T; Nabeta M; Yajima K; Imaoka A; Ohtani H
Biol Pharm Bull; 2023; 46(12):1745-1752. PubMed ID: 38044133
[TBL] [Abstract][Full Text] [Related]
6. Chiral Transplacental Pharmacokinetics of Fexofenadine: Impact of P-Glycoprotein Inhibitor Fluoxetine Using the Human Placental Perfusion Model.
Pinto L; Bapat P; de Lima Moreira F; Lubetsky A; de Carvalho Cavalli R; Berger H; Lanchote VL; Koren G
Pharm Res; 2021 Apr; 38(4):647-655. PubMed ID: 33825113
[TBL] [Abstract][Full Text] [Related]
7. The Role of P-Glycoprotein in Decreasing Cell Membranes Permeability during Oxidative Stress.
Shchulkin AV; Abalenikhina YV; Erokhina PD; Chernykh IV; Yakusheva EN
Biochemistry (Mosc); 2021 Feb; 86(2):197-206. PubMed ID: 33832418
[TBL] [Abstract][Full Text] [Related]
8. Possible Regulation of P-Glycoprotein Function by Adrenergic Agonists II: Study with Isolated Rat Jejunal Sheets and Caco-2 Cell monolayers.
Mukai H; Takanashi M; Ogawara KI; Maruyama M; Higaki K
J Pharm Sci; 2024 May; 113(5):1209-1219. PubMed ID: 37984697
[TBL] [Abstract][Full Text] [Related]
9. Effects of hypoxia on the expression and function of P-gp in Caco-2 cells.
Zhao A; Mu H; Yao W; Chang X; Li W; Wang R
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 48(4):491-498. PubMed ID: 37385611
[TBL] [Abstract][Full Text] [Related]
10. Significance of Basal Membrane Permeability of Epithelial Cells in Predicting Intestinal Drug Absorption.
Yoshitomo A; Asano S; Hozuki S; Tamemoto Y; Shibata Y; Hashimoto N; Takahashi K; Sasaki Y; Ozawa N; Kageyama M; Iijima T; Kazuki Y; Sato H; Hisaka A
Drug Metab Dispos; 2023 Mar; 51(3):318-328. PubMed ID: 36810197
[TBL] [Abstract][Full Text] [Related]
11. Studies on pharmacokinetic properties and absorption mechanism of phloretin: In vivo and in vitro.
Zhao YY; Fan Y; Wang M; Wang J; Cheng JX; Zou JB; Zhang XF; Shi YJ; Guo DY
Biomed Pharmacother; 2020 Dec; 132():110809. PubMed ID: 33049584
[TBL] [Abstract][Full Text] [Related]
12. Case Study 8: Status of the Structural Mass Action Kinetic Model of P-gp-Mediated Transport Through Confluent Cell Monolayers.
Bentz J; Ellens H
Methods Mol Biol; 2021; 2342():737-763. PubMed ID: 34272715
[TBL] [Abstract][Full Text] [Related]
13. Intestinal absorption mechanism of rotundic acid: Involvement of P-gp and OATP2B1.
Shang H; Sun Y; Wang Z; Zhou Y; Yang H; Ci X; Cui T; Xia Y; Gu Y; Liao M; Li Q; Si D; Liu C
J Ethnopharmacol; 2022 May; 289():115006. PubMed ID: 35051604
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the Uptake and Transport of Two Novel Camptothecin Derivatives in Caco-2 Cell Monolayers.
Wang Y; Zhang X; Zhuang W; Yu Y; Sun X; Wang H; Li F; Li Q
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744795
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the transport kinetics of fexofenadine and its pH dependency among OATP1A2 genetic variants.
Han H; Akiyoshi T; Morita T; Kataoka H; Katayama K; Yajima K; Imaoka A; Ohtani H
Drug Metab Pharmacokinet; 2022 Dec; 47():100470. PubMed ID: 36116173
[TBL] [Abstract][Full Text] [Related]
16. Fexofenadine Plasma Concentrations to Estimate Systemic Exposure in Healthy Adults Using a Limited Sampling Strategy with a Population Pharmacokinetic Approach.
Piscitelli J; Nikanjam M; Capparelli EV; Blaquera CL; Penzak SR; Nolin TD; Paine MF; Ma JD
Ther Drug Monit; 2023 Aug; 45(4):539-545. PubMed ID: 36645711
[TBL] [Abstract][Full Text] [Related]
17. In vitro intestinal transport and anti-inflammatory properties of ideain across Caco-2 transwell model.
Denaro M; Smeriglio A; De Francesco C; Xiao J; Cornara L; Trombetta D
Fitoterapia; 2020 Oct; 146():104723. PubMed ID: 32949649
[TBL] [Abstract][Full Text] [Related]
18. Intestinal Absorption of Alogliptin Is Mediated by a Fruit-Juice-Sensitive Transporter.
Morimoto K; Sasaki M; Oikawa E; Abe M; Kikuchi T; Ishii M; Ogihara T; Tomita M
Biol Pharm Bull; 2021; 44(5):653-658. PubMed ID: 33952821
[TBL] [Abstract][Full Text] [Related]
19. Use of Fluorescent 2-AB to Explore the Bidirectional Transport Mechanism of
Yang B; Li Y; Shi W; Liu Y; Kan Y; Chen J; Hu J; Pang W
Molecules; 2022 May; 27(10):. PubMed ID: 35630667
[TBL] [Abstract][Full Text] [Related]
20. Rapid Increase of Gastrointestinal P-Glycoprotein Functional Activity in Response to Etoposide Stimulation.
Yano K; Kimura M; Watanabe Y; Ogihara T
Biol Pharm Bull; 2021; 44(5):701-706. PubMed ID: 33952826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
